The Recall Desk
HighFDA (Drugs)·D-1514-2019·Announced 2019-07-31

Baxter Recalls Sodium Chloride Injection Due to Sterility Concerns

Baxter Healthcare is recalling 139,680 containers of 0.9% Sodium Chloride Injection due to a lack of assurance of sterility and potential for bags to leak.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (sterility failure in an IV drug) where injury has not yet been reported, fitting the High severity criteria.

Plain-English summary

Baxter Healthcare Corporation is recalling 139,680 containers of 0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container. The affected product is identified by NDC 0338-0049-38 and includes Lot #s P389684 and P389742, with an expiration date of 8/31/2020.

The recall was initiated because the bags have the potential to leak, resulting in a lack of assurance of sterility. This product is a prescription-only intravenous medication manufactured by Baxter Healthcare Corporation in Deerfield, IL.

The affected units were distributed nationwide in the United States and Puerto Rico. Healthcare providers and patients should stop using the affected lots and contact Baxter Healthcare Corporation for further instructions or replacement.

The recalled product

Product
SODIUM CHLORIDE (SODIUM CHLORIDE)
Brand
SODIUM CHLORIDE
Affected units
139,680

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot #s: P389684
  • P389742
  • Exp. 8/31/2020

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically: